MBX
MBX BIO (MBX)
NASDAQ
$30.05-$0.65 (-2.13%)
Price as of Jun 03, 2026 4:35 PM EDT
  • $1.5B
    Market Cap
  • 124.74%
    1-Year Change
  • Biotechnology
    Industry
Annual
Quarterly
12/31/2025
12/31/2024
Income Statement
Total Operating Revenue
N/A
N/A
N/A
N/A
Cost of Revenue
N/A
N/A
N/A
N/A
Gross Profit
0
N/A
0
N/A
Sales and Marketing Expense
N/A
N/A
N/A
N/A
Research and Development Expense
-79.2M
+37.87%
-57.4M
N/A
Depreciation and Amortization Expense
248,000
+1.64%
244,000
N/A
Total Operating Expenses
98.1M
+43.79%
68.2M
N/A
Operating Profit
-98.1M
+43.79%
-68.2M
N/A
Interest Income
11.1M
+76.72%
6.3M
N/A
Interest Expense
N/A
N/A
N/A
N/A
Interest Income and Expense and Net
11.1M
+76.72%
6.3M
N/A
Total Nonoperating Income and Expense
N/A
N/A
N/A
N/A
Income before Taxes
-87.0M
+40.45%
-61.9M
N/A
Income Taxes
0
N/A
0
N/A
Extraordinary Items
N/A
N/A
N/A
N/A
Net Income
-87.0M
+40.45%
-61.9M
N/A
Net Income from Continuing Operations Applicable to Common
-87.0M
+40.45%
-61.9M
N/A
Basic EPS and Net Income
-2.38
-59.11%
-5.82
N/A
Diluted EPS and Net Income
-2.38
-59.11%
-5.82
N/A
Basic Weighted Average Shares
36.5M
+243.01%
10.6M
N/A
Diluted Weighted Average Shares
36.5M
+243.01%
10.6M
N/A
Balance Sheet
Cash and Cash Equivalents
75.3M
+52.56%
49.4M
N/A
Short-Term Investments
298.4M
+40.23%
212.8M
N/A
Cash and Cash Equivalents and Short-Term Investments
373.7M
+42.55%
262.1M
N/A
Total Current Assets
381.5M
+42.75%
267.3M
N/A
Accumulated Depreciation
670,000
+58.77%
422,000
N/A
Property and Plant and Equipment and Net
2.7M
+153.24%
1.1M
N/A
Total Long-Term Assets
383,000
+666.00%
50,000
N/A
Total Assets
385.1M
+43.42%
268.5M
N/A
Income Taxes Payable
N/A
N/A
N/A
N/A
Total Short-Term Debt
N/A
N/A
N/A
N/A
Total Current Liabilities
15.5M
+40.21%
11.1M
N/A
Total Long-Term Debt
N/A
N/A
N/A
N/A
Total Long-Term Liabilities
424,000
N/A
0
N/A
Total Liabilities
15.9M
+43.52%
11.1M
N/A
Retained Earnings
-224.5M
+63.25%
-137.5M
N/A
Total Stockholders Equity
369.2M
+43.42%
257.4M
N/A
Total Shares Outstanding
44.9M
+34.43%
33.4M
N/A
Cash Flow
Cash from Operating Activities
-79.9M
+46.21%
-54.7M
N/A
Capital Expenditures
1.9M
+120.71%
874,000
N/A
Cash from Investing Activities
-83.7M
-47.88%
-160.6M
N/A
Dividends Paid
N/A
N/A
N/A
N/A
Cash from Financing Activities
189.6M
-19.01%
234.1M
N/A
Financials Ratio
Gross Margin
N/A
N/A
N/A
N/A
Operating Margin
N/A
N/A
N/A
N/A
Return on Assets
-26.61%
N/A
N/A
N/A
Return on Equity
-27.76%
N/A
N/A
N/A
Revenue Growth
N/A
N/A
N/A
N/A
Current Ratio
24.62
N/A
N/A
N/A
Cash Ratio
4.86
N/A
N/A
N/A
Debt-to-Equity Ratio
N/A
N/A
N/A
N/A
Debt-to-Assets Ratio
N/A
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow